These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2473123)

  • 1. The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence.
    Dintzis RZ; Okajima M; Middleton MH; Greene G; Dintzis HM
    J Immunol; 1989 Aug; 143(4):1239-44. PubMed ID: 2473123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antibody formation by receptor cross-linking: the molecular characteristics of inhibitory haptenated polymers.
    Dintzis RZ; Okajima M; Middleton MH; Dintzis HM
    Eur J Immunol; 1990 Jan; 20(1):229-32. PubMed ID: 1689663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones.
    Siliciano RF; Keegan AD; Dintzis RZ; Dintzis HM; Shin HS
    J Immunol; 1985 Aug; 135(2):906-14. PubMed ID: 2409158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the immunogenicity and tolerogenicity of T-independent antigens.
    Dintzis RZ; Middleton MH; Dintzis HM
    J Immunol; 1983 Nov; 131(5):2196-203. PubMed ID: 6631009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of anti-DNP antibody formation by high doses of DNP-polyacrylamide molecules; effects of hapten density and hapten valence.
    Dintzis RZ; Middleton MH; Dintzis HM
    J Immunol; 1985 Jul; 135(1):423-7. PubMed ID: 3889155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two signals are required for accessory cells to induce B cell unresponsiveness. Tolerogenic Ig and prostaglandin.
    Schad VC; Phipps RP
    J Immunol; 1988 Jul; 141(1):79-84. PubMed ID: 2454266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunological properties of haptens coupled to thymus-independent carrier molecules. III. The role of the immunogenicity and mitogenicity of the carrier in the induction of primary IgM anti-hapten responses.
    Klaus GG; Janossy G; Humphrey JH
    Eur J Immunol; 1975 Feb; 5(2):105-11. PubMed ID: 10166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates.
    Lee WY; Sehon AH
    J Immunol; 1976 Jun; 116(6):1711-8. PubMed ID: 58048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VI. Response in B-cell-defective CBA/N mice.
    Snippe H; van Houte AJ; Lizzio EF; Willers JM; Merchant B
    Immunology; 1982 Mar; 45(3):545-51. PubMed ID: 6174426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary antibody responses to hapten-modified syngeneic cells: exceptional immunogenicity of erythrocytes.
    Nakashima I; Takashi M; Nagase F; Kato N
    Eur J Immunol; 1981 Nov; 11(11):946-8. PubMed ID: 6799301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of self carriers in the immune response and tolerance. X. A lymphoid dendritic-like tumor, P388AD.2, acts as a novel immunogenic carrier for hapten.
    Cogswell JP; Phipps RP; Scott DW
    J Immunol; 1986 Aug; 137(3):777-83. PubMed ID: 3522737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response.
    Zigterman GJ; Snippe H; Jansze M; Willers JM
    J Immunol; 1987 Jan; 138(1):220-5. PubMed ID: 3782798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VII. Synergistic responses to haptenated liposomes and haptenated thymus-dependent antigens in CBA/N mice.
    Snippe H; Van Houte AJ; Janssen A; Lizzio EF; Willers JM; Merchant B
    Immunology; 1982 Apr; 45(4):613-20. PubMed ID: 6175564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cells.
    Cowdery JS; Laskin CA; Steinberg AD
    J Immunol; 1982 Apr; 128(4):1571-6. PubMed ID: 6174607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific stimulation and suppression of a primary in vitro plaque-forming cell response by monovalent lipid haptens in fluid liposomal membranes.
    Humphries GM
    J Immunol; 1979 Nov; 123(5):2126-32. PubMed ID: 573772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of a tolerogenic to an immunogenic signal by P388AD.2 cells, a lymphoid dendritic cell-like tumor line.
    Phipps RP; Pillai PS; Scott DW
    J Immunol; 1984 May; 132(5):2273-8. PubMed ID: 6201539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. I. Thymus independence of the antigen.
    van Houte AJ; Snippe H; Willers JM
    Immunology; 1979 Jun; 37(2):505-14. PubMed ID: 381183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of monoclonal anti-fluorescein antibodies from autoimmune New Zealand mice.
    Ballard DW; Bates RM; Voss EW
    J Immunol; 1985 Jul; 135(1):433-9. PubMed ID: 3889156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reappraisal of "T-independent" antigens. II. Studies on single, hapten-specific B cells from neonatal CBA/H or CBA/N mice fail to support classification into TI-1 and TI-2 categories.
    Nossal GJ; Pike BL
    J Immunol; 1984 Apr; 132(4):1696-701. PubMed ID: 6199408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-induced epitopic suppression is initiated through clonal dominance.
    Schutze MP; Deriaud E; Przewlocki G; LeClerc C
    J Immunol; 1989 Apr; 142(8):2635-40. PubMed ID: 2467933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.